These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 30209648)

  • 1. Early ophthalmologic features of Parkinson's disease: a review of preceding clinical and diagnostic markers.
    Turcano P; Chen JJ; Bureau BL; Savica R
    J Neurol; 2019 Sep; 266(9):2103-2111. PubMed ID: 30209648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ophthalmologic features of Parkinson's disease.
    Biousse V; Skibell BC; Watts RL; Loupe DN; Drews-Botsch C; Newman NJ
    Neurology; 2004 Jan; 62(2):177-80. PubMed ID: 14745050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diplopia in Parkinson's disease: visual illusion or oculomotor impairment?
    Visser F; Vlaar AMM; Borm CDJM; Apostolov V; Lee YX; Notting IC; Weinstein HC; Berendse HW
    J Neurol; 2019 Oct; 266(10):2457-2464. PubMed ID: 31214767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual Dysfunction in Parkinson's Disease.
    Armstrong RA
    Int Rev Neurobiol; 2017; 134():921-946. PubMed ID: 28805589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ophthalmic disorders as a manifestation of Parkinson's disease].
    Chesnokova NB; Pavlenko TA; Ugrumov MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):124-131. PubMed ID: 29053133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional neuroimaging in patients with Parkinson's disease and visual hallucinations: A critical review.
    Lenka A; Jhunjhunwala KR; Saini J; Pal PK
    Parkinsonism Relat Disord; 2015 Jul; 21(7):683-91. PubMed ID: 25920541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Visual Dysfunction in Patients with Parkinson's Disease.
    Savitt J; Aouchiche R
    J Parkinsons Dis; 2020; 10(s1):S49-S56. PubMed ID: 32741840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of dementia and visual hallucinations in tremor and non-tremor dominant Parkinson's disease.
    Rana AQ; Vaid HM; Edun A; Dogu O; Rana MA
    J Neurol Sci; 2012 Dec; 323(1-2):158-61. PubMed ID: 23062324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual complaints and visual hallucinations in Parkinson's disease.
    Urwyler P; Nef T; Killen A; Collerton D; Thomas A; Burn D; McKeith I; Mosimann UP
    Parkinsonism Relat Disord; 2014 Mar; 20(3):318-22. PubMed ID: 24405755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomography in Parkinson's disease: is the retina a biomarker?
    Lee JY; Ahn J; Kim TW; Jeon BS
    J Parkinsons Dis; 2014; 4(2):197-204. PubMed ID: 24518436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between visual hallucinations and REM sleep behavior disorder in patients with Parkinson's disease.
    Meral H; Aydemir T; Ozer F; Ozturk O; Ozben S; Erol C; Cetin S; Hanoglu L; Ozkayran T; Yilsen M
    Clin Neurol Neurosurg; 2007 Dec; 109(10):862-7. PubMed ID: 17913346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive identification of delusions and olfactory, tactile, gustatory, and minor hallucinations in Parkinson's disease psychosis.
    Kulick CV; Montgomery KM; Nirenberg MJ
    Parkinsonism Relat Disord; 2018 Sep; 54():40-45. PubMed ID: 29653909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing an aetiological model of visual hallucinations in Parkinson's disease.
    Gallagher DA; Parkkinen L; O'Sullivan SS; Spratt A; Shah A; Davey CC; Bremner FD; Revesz T; Williams DR; Lees AJ; Schrag A
    Brain; 2011 Nov; 134(Pt 11):3299-309. PubMed ID: 21921019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oculo-visual abnormalities in Parkinson's disease: Possible value as biomarkers.
    Guo L; Normando EM; Shah PA; De Groef L; Cordeiro MF
    Mov Disord; 2018 Sep; 33(9):1390-1406. PubMed ID: 30311977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minor retinal degeneration in Parkinson's disease.
    Huang YM; Yin ZQ
    Med Hypotheses; 2011 Feb; 76(2):194-6. PubMed ID: 20933338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of visual hallucinations, rapid eye movement sleep behavior disorder and cognitive impairment in Parkinson's disease: A review.
    Lenka A; Hegde S; Jhunjhunwala KR; Pal PK
    Parkinsonism Relat Disord; 2016 Jan; 22():1-8. PubMed ID: 26639978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease.
    Lee JY; Kim JM; Ahn J; Kim HJ; Jeon BS; Kim TW
    Mov Disord; 2014 Jan; 29(1):61-7. PubMed ID: 23775932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional changes in the retina in Parkinson's disease.
    Alves JN; Westner BU; Højlund A; Weil RS; Dalal SS
    J Neurol Neurosurg Psychiatry; 2023 Jun; 94(6):448-456. PubMed ID: 36806480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hallucinations in Parkinson's disease].
    Moser A; Hagenah J; Kömpf D
    Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease, visual hallucinations and apomorphine: A review of the available evidence.
    Borgemeester RW; Lees AJ; van Laar T
    Parkinsonism Relat Disord; 2016 Jun; 27():35-40. PubMed ID: 27132157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.